Association of renin BglI polymphism with essential hypertension: A meta-analysis involving 1811 cases and 1626 controls

Clinical and Experimental Hypertension

Volumn 32, Issue 7, 2010, Pages 431-438

  Niu, Wenquan ^a   Qi, Yue ^b   Guo, Shujie ^a   Gao, Pingjin ^a,c   Zhu, Dingliang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Association; BglI polymorphism; Essential hypertension; Meta analysis; Renin

Indexed keywords

ALLELE; ARTICLE; CLINICAL TRIAL; ESSENTIAL HYPERTENSION; GENE; GENETIC POLYMORPHISM; HUMAN; META ANALYSIS; PUBLISHING; RENIN BGLI; SYSTEMATIC REVIEW;

ADULT; ALLELES; BLOOD PRESSURE; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERTENSION; INHERITANCE PATTERNS; MALE; MODELS, STATISTICAL; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RENIN; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; VASOCONSTRICTION;

EID: 78049458176     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641961003686419     Document Type: Article

References (28)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001;104:545-556.
2. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007;370:591-603.
3. Niu W, Qi Y, Cen W, et al. Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population. Hypertens Res 2007;30:1129-1137.
4. Niu WQ, Qi Y, Zhang LT, et al. Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study. J Hum Hypertens 2009; 23:136-139.
5. Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens 2009;27:1384-1391.
6. Pollex RL, Hegele RA. Copy number variation in the human genome and its implications for cardiovascular disease. Circulation 2007;115:3130-3138.
7. Mourad JJ, Le Jeune S. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress. J Hypertens 2008;26:S7-S14.
8. Jeunemaitre X. Genetics of the human renin angiotensin system. J Mol Med 2008;86: 637-641.
9. Campbell DJ, Bouhnik J, Ménard J, Corvol P. Identity of angiotensinogen precursors of rat brain and liver. Nature 1984;308:206-208.
10. Siragy HM. Renin inhibition: a new modality for hypertension management. Curr Hypertens Rep 2007;9:291-294.
11. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med 2008;264: 224-236.
12. Markus MA, Goy C, Adams DJ, Lovicu FJ, Morris BJ. Renin enhancer is crucial for full response in Renin expression to an in vivo stimulus. Hypertension 2007;50:933-938.
13. Morris BJ. Fluorescence activated cell sorting of transiently transfected As4.1 cells shows renin enhancer directs on/off switching of renin promoter in vitro. Clin Exp Pharmacol Physiol 2008;35:367-371.
14. Qi Y, Niu W, Cen W, et al. Strong association of the renin TaqI polymorphism with essential hypertension in Chinese Han and Tibetan populations. J Hum Hypertens 2007; 21:907-910.
15. Moore N, Dicker P, O'Brien JK, et al. Renin gene polymor-phisms and haplotypes, blood pressure, and responses to renin-angiotensin system inhibition. Hypertension 2007;50: 340-347.
16. Mansego ML, Redon J, Marin R, et al. Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens 2008;26:230-237.
17. Zhu X, Chang YP, Yan D, et al. Associations between hypertension and genes in the renin-angiotensin system. Hypertension 2003;41: 1027-1034.
18. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2:91-99.
19. Thakkinstian A, McEvoy M, Minelli C, et al. Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma: A HuGE review. Am J Epidemiol 2005;162:201-211.
20. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-826.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
22. Ioannidis JP, Trikalinos TA. Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 2005;58:543-549.
23. Naftilan AJ, Williams R, Burt D, et al. A lack of genetic linkage of renin gene restriction fragment length polymor-phisms with human hypertension. Hypertension 1989;14: 614-618.
24. Frossard PM, Malloy MJ, Lestringant GG, Kane JP. Haplotypes of the human renin gene associated with essential hypertension and stroke. J Hum Hypertens 2001;15:49-55.
25. Chiang FT, Hsu KL, Tseng CD, Lo HM, Chern TH, Tseng YZ. Association of the renin gene polymorphism with essential Hypertension in a Chinese population. Clin Genet 1997; 51:370-374.
26. Frossard PM, Lestringant GG, Malloy MJ, Kane JP. Human renin gene BglI dimorphism associated with Hypertension in two independent populations. Clin Genet 1999;56: 428-433.
27. Wang Y, O'Connell JR, McArdle PF, et al. Whole-genome association study identifies STK39 as a hypertension suscepti-bility gene. Proc Natl Acad Sci USA 2009;106: 226-231.
28. Helgadottir A, Manolescu A, Helgason A, et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2006;38:68-74.